GLP-1 Half-Life Calculator

Compare active blood levels across the major GLP-1s. Switch compounds, change dose and schedule, and see how each curve builds to steady state.

Active levels

Semaglutide

Half-life 7.0 days·tMax 34h

SourceFDA Ozempic label (NDA 209637)
mg
0.00000.631.251.882.50mg-equivStartW1W2W3W4W5W6W7W8
Estimated active level
Dose
Steady-state band
Steady-state peak
1.79mg
Trough
1.03mg
Trough as % of peak
58%
Time to steady state
~5wks
Keep your compounds in Regimen and see your levels between doses.Add to Regimen

Population-average pharmacokinetic model. Individual variation is significant. Not medical advice. See the methodology.

This tool is for informational purposes only, so always double-check your result with a healthcare provider. Levels shown are estimates from a population-average pharmacokinetic model, not a dosing recommendation, and individual variation is significant. We assume no liability for dosing errors.

The tool

How it works, what it tells you, what it doesn't.

The GLP-1 half-life calculator uses the Bateman absorption-and-elimination model (the same math the Regimen app uses) to simulate how a GLP-1 dose accumulates and clears over time. Pick any of the four approved-or-investigational injectable GLP-1s and set a dose and schedule. The chart shows the curve, the peak and trough at steady state, and how long it takes to reach steady state. Semaglutide's 7-day half-life produces the flattest weekly profile; tirzepatide's 5-day half-life trades stability for faster washout; retatrutide sits between them; liraglutide requires daily dosing because its 13-hour half-life can't sustain a weekly schedule.

How to use it

How to use the GLP-1 half-life calculator

  1. 01

    Pick the compound

    Semaglutide, tirzepatide, liraglutide, or retatrutide. Each loads its own half-life and time-to-peak.

  2. 02

    Set the dose

    Enter the dose per injection in mg. Common starting doses populate by default.

  3. 03

    Choose the schedule

    Weekly is standard for semaglutide, tirzepatide, and retatrutide. Liraglutide is daily.

  4. 04

    Read the curve

    The chart shows estimated active levels building to steady state. Stats show peak, trough, and the time to converge.

GLP-1 half-life comparison

CompoundBrandHalf-lifeScheduleSteady state
SemaglutideOzempic, Wegovy~7 daysWeekly~5 weeks
TirzepatideMounjaro, Zepbound~5 daysWeekly~4 weeks
RetatrutidePhase 3 (not approved)~6 daysWeekly~4–5 weeks
DulaglutideTrulicity~5 daysWeekly~4 weeks
LiraglutideSaxenda, Victoza~13 hoursDaily~3 days

What half-life actually tells you

Half-life is the time it takes for the concentration of a drug in your blood to drop by 50 percent. For GLP-1 medications it determines three things you actually experience: how often you have to inject, how flat or peaky your weekly levels feel, and how long the drug keeps working after your last dose.

The big design split among GLP-1s is between liraglutide (a first-generation compound that clears quickly and requires daily dosing) and the modern once-weekly GLP-1s. Once-weekly compounds use either albumin binding (semaglutide, tirzepatide, retatrutide) or Fc-fusion (dulaglutide) to extend the half-life into the multi-day range. That is what makes weekly dosing pharmacologically clean.

Steady state is the point at which weekly intake equals weekly clearance. It takes about 4 to 5 half-lives to get there. That is also the window for full washout after you stop. For semaglutide at 7 days, both numbers land at roughly 5 weeks. For tirzepatide at 5 days, both land at 4 weeks. For liraglutide at 13 hours, it is 3 days.

Longer half-life is not automatically better. It produces flatter weekly levels, which usually means smoother GI side effect profiles. But it also means slower wash-in (you wait longer to feel a dose change) and slower wash-out (you can’t pivot fast if you have a side effect issue). Choose by what your prescriber recommends, not by half-life alone.

For deeper compound-specific math, open the semaglutide or tirzepatide half-life pages.

Get the app

See your real GLP-1 curve in the app

Regimen logs each weekly injection and builds your personal active-level curve, with reminders, dose titration tracking, and Apple Health correlation.

  • Personalized PK curves
  • Smart injection reminders
  • Body composition correlation
  • Private, secure health data

Free to download. Free for your first compound.

Regimen app Today view with doses and estimated levels

Questions

Frequently Asked Questions

Why do GLP-1 half-lives vary so widely?

Newer once-weekly GLP-1s (semaglutide, tirzepatide, dulaglutide, retatrutide) use albumin binding or Fc-fusion to extend their half-life into the multi-day range. Liraglutide, the older once-daily GLP-1, lacks that engineering and clears in roughly half a day.

Which GLP-1 has the longest half-life?

Among approved compounds, semaglutide at approximately 7 days. Retatrutide (currently in Phase 3 trials) sits between tirzepatide and semaglutide at approximately 6 days. Dulaglutide and tirzepatide are both approximately 5 days. Liraglutide is 13 hours.

Does a longer half-life mean better results?

Not directly. The compound's intrinsic efficacy at its target receptors matters far more than half-life alone. Half-life primarily affects dosing convenience, peak-to-trough variance, and washout duration.

How quickly does each GLP-1 reach steady state?

Roughly 4 to 5 half-lives. Liraglutide: about 3 days. Tirzepatide, dulaglutide: about 4 to 5 weeks. Semaglutide: about 5 weeks. Retatrutide: about 4 to 5 weeks.

How long does each GLP-1 stay in your system after stopping?

Clinically meaningful exposure ends at roughly 4 to 5 half-lives. Liraglutide washes out in 2 to 3 days. Tirzepatide takes 4 to 5 weeks. Semaglutide takes 5 to 7 weeks.